Subsequently, the immune checkpoint inhibitors (ICIs) that antiprogrammed cell death protein 1 (PD‐1), CTLA‐4 have increasingly been used for the treatment of HCC.18, 19. Here, CTLA4 is linked to hepatocellular carcinoma.